labetalol has been researched along with thromboxane a2 in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirose, K; Okuda, C; Sakio, H | 1 |
Calder, AA; Forbes, CD; Greer, IA; McLaren, M; Walker, JJ | 2 |
Viinikka, L; Ylikorkala, O | 1 |
Jouppila, P; Kirkinen, P; Koivula, A; Ylikorkala, O | 1 |
Forman, A; Gregersen, H; Petersen, OB; Skajaa, K; Svane, D | 1 |
Semczuk, M; SkoczyĆski, M | 1 |
7 other study(ies) available for labetalol and thromboxane a2
Article | Year |
---|---|
[The participation of the sympathetic nervous system in thromboxane A2 release induced by limb ischemia].
Topics: Animals; Bupivacaine; Dogs; Ischemia; Labetalol; Leg; Sympathetic Nervous System; Thromboxane A2; Thromboxane B2 | 1989 |
Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Atenolol; Epoprostenol; Humans; Labetalol; Pindolol; Propranolol; Thromboxane A2; Thromboxane B2 | 1985 |
A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation.
Topics: Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Labetalol; Pindolol; Platelet Aggregation; Prazosin; Propranolol; Thromboxane A2; Thromboxane B2 | 1985 |
Beta blockers inhibit fetal thromboxane A2 production in vitro.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Platelets; Female; Fetal Blood; Humans; Infant, Newborn; Kinetics; Labetalol; Metoprolol; Pregnancy; Propranolol; Thromboxane A2 | 1988 |
Labetalol does not alter the placental and fetal blood flow or maternal prostanoids in pre-eclampsia.
Topics: Blood Pressure; Epoprostenol; Female; Fetus; Heart Rate; Hemodynamics; Humans; Labetalol; Placenta; Pre-Eclampsia; Pregnancy; Regional Blood Flow; Thromboxane A2 | 1986 |
The effects of dihydralazine, labetalol and magnesium sulphate on the isolated, perfused human placental cotyledon.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Dihydralazine; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Labetalol; Magnesium Sulfate; Placenta; Pregnancy; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Vasoconstrictor Agents; Vasodilation | 1994 |
[Influence of labetalol on the resistance of human fetoplacental vessels in perfusion in vitro].
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Dose-Response Relationship, Drug; Female; Fetus; Humans; In Vitro Techniques; Labetalol; Placenta; Placental Circulation; Pregnancy; Thromboxane A2; Vascular Resistance; Vasoconstrictor Agents | 2002 |